PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Passerini, V.* ; Bösl, M.R. ; Silkenstedt, E.* ; Osterode, E.* ; Heide, M.* ; Kridel, R.* ; Ziegenhain, C.* ; Staiger, A.M.* ; Ott, G.* ; Szczepanowski, M.* ; Richter, J.* ; Klapper, W.* ; Rosenwald, A.* ; Enard, W.* ; Hiddemann, W.* ; Bararia, D.* ; Zimber-Strobl, U. ; Weigert, O.*

PARP14 is a novel therapeutic target in STAT6 mutant follicular lymphoma.

Blood 132 (2018)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
Web of Science
Times Cited
Altmetric
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language
Publication Year 2018
HGF-reported in Year 2018
ISSN (print) / ISBN 0006-4971
e-ISSN 1528-0020
Journal Blood
Quellenangaben Volume: 132 Issue: , Pages: , Article Number: , Supplement: ,
Publisher American Society of Hematology
Publishing Place 2021 L St Nw, Suite 900, Washington, Dc 20036 Usa
Reviewing status Peer reviewed
Institute(s) Research Unit Gene Vector (AGV)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-501500-003
DOI 10.1182/blood-2018-99-118063
WOS ID WOS:000454842800043
Erfassungsdatum 2019-03-01
[➜Report correction]